The photocytotoxicity and photobiochemical properties of the new complex trans, trans, trans-[Pt(N3)2(OH)2(NH3)(piperidine)] (5) are compared with its analogue containing the less basic and less lipophilic ligand pyridine (4). The log P (n-octanol/water) values were of -1.16 and -1.84 for the piperidine and pyridine complexes, respectively, confirmed that piperidine increases the hydrophobicity of the complex. DFT and TDDFT calculations indicate that 5 has accessible singlet and triplet states which can promote ligand dissociation when populated by both UVA and visible white light. When activated by UVA or white light, both compounds showed similar cytotoxic potencies in various human cancer cell lines although their selectivity was differe...
trans-Platinum complexes have been the landmark in unconventional drugs prompting the development of...
The Pt(IV) prodrug trans, trans, trans-[Pt(pyridine)2(N3)2(OH)2] (Pt1) and its coumarin derivative t...
Platinum(II) complexes containing the strong π-acceptor N,N-chelating ligand phenylazopyridine (Ph-a...
The Pt IV diazido complex trans,trans,trans-[Pt(N 3) 2(OH) 2(pyridine) 2] (1) is unreactive in the d...
A photoactivatable platinum(IV) complex, trans,trans,trans-[Pt(N3)2(OH)(succ)(py)2] (succ=succinylat...
Platinum diam(m)ine complexes, such as cisplatin, are successful anticancer drugs, but suffer from p...
Photoactivatable agents offer the prospect of highly selective cancer therapy with low side effects ...
Novel all-trans dinuclear PtIV complexes bridged by a dicarboxylate linker, highly stable in the dar...
Complexes trans,trans,trans-[Pt(N-3)(2)(OH)(OCOR)(py)(2)] where py = pyridine and where OCOR = succi...
SummaryA possible way to avoid dose-limiting side effects of platinum anticancer drugs is to employ ...
Photoactive platinum compounds have the potential to reduce some of the debilitating side-effects as...
Photoactivatable Pt(IV) diazido complexes have unusual photobiologic properties. We show here that t...
We show that UVA irradiation (365 nm) of the Pt-IV complex trans,trans,trans-[(PtCl2)-Cl-IV(OH)(2)(d...
A major challenge of platinum anticancer therapy lies in overcoming the severe side-effects associa...
The synthesis, characterisation and properties of novel photosensitive Pt(II) complexes [Pt(terpyrid...
trans-Platinum complexes have been the landmark in unconventional drugs prompting the development of...
The Pt(IV) prodrug trans, trans, trans-[Pt(pyridine)2(N3)2(OH)2] (Pt1) and its coumarin derivative t...
Platinum(II) complexes containing the strong π-acceptor N,N-chelating ligand phenylazopyridine (Ph-a...
The Pt IV diazido complex trans,trans,trans-[Pt(N 3) 2(OH) 2(pyridine) 2] (1) is unreactive in the d...
A photoactivatable platinum(IV) complex, trans,trans,trans-[Pt(N3)2(OH)(succ)(py)2] (succ=succinylat...
Platinum diam(m)ine complexes, such as cisplatin, are successful anticancer drugs, but suffer from p...
Photoactivatable agents offer the prospect of highly selective cancer therapy with low side effects ...
Novel all-trans dinuclear PtIV complexes bridged by a dicarboxylate linker, highly stable in the dar...
Complexes trans,trans,trans-[Pt(N-3)(2)(OH)(OCOR)(py)(2)] where py = pyridine and where OCOR = succi...
SummaryA possible way to avoid dose-limiting side effects of platinum anticancer drugs is to employ ...
Photoactive platinum compounds have the potential to reduce some of the debilitating side-effects as...
Photoactivatable Pt(IV) diazido complexes have unusual photobiologic properties. We show here that t...
We show that UVA irradiation (365 nm) of the Pt-IV complex trans,trans,trans-[(PtCl2)-Cl-IV(OH)(2)(d...
A major challenge of platinum anticancer therapy lies in overcoming the severe side-effects associa...
The synthesis, characterisation and properties of novel photosensitive Pt(II) complexes [Pt(terpyrid...
trans-Platinum complexes have been the landmark in unconventional drugs prompting the development of...
The Pt(IV) prodrug trans, trans, trans-[Pt(pyridine)2(N3)2(OH)2] (Pt1) and its coumarin derivative t...
Platinum(II) complexes containing the strong π-acceptor N,N-chelating ligand phenylazopyridine (Ph-a...